GT Medical Technologies raises $100m for brain tumour therapy advance
GT Medical Technologies recently presented final data from a Phase III study of its GammaTile radiation therapy versus the SoC at this year’s ASCO meeting.
10 June 2026
10 June 2026
GT Medical Technologies recently presented final data from a Phase III study of its GammaTile radiation therapy versus the SoC at this year’s ASCO meeting.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.